Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA. uri icon

Overview

abstract

  • [This corrects the article DOI: 10.1038/celldisc.2015.40.].

publication date

  • August 30, 2016

Identity

PubMed Central ID

  • PMC5004231

Scopus Document Identifier

  • 85022185145

Digital Object Identifier (DOI)

  • 10.1038/celldisc.2016.32

PubMed ID

  • 27625791

Additional Document Info

volume

  • 2